Understand the source comparison
How to Read Adamax CoA: Comparison of Key Data Points
HPLC Purity Percentage of target peptide vs total detectable compounds ≥95% ≥98% Multiple peaks >1%, broad/split peaks, baseline drift Single dominant peak at expected retention time with <1% secondary peaks confirms synthesis quality and minimal degradation M
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- HPLC Purity
- Percentage of target peptide vs total detectable compounds
- ≥95%
- ≥98%
- Multiple peaks >1%, broad/split peaks, baseline drift
- Single dominant peak at expected retention time with <1% secondary peaks confirms synthesis quality and minimal degradation
- Mass Spectrometry
- Molecular weight match to confirm sequence identity
- ±1.0 Da from expected MW
- ±0.5 Da from expected MW
- Delta >1.0 Da, unexpected oxidation state, missing disulphide confirmation
- Observed MW within ±0.5 Da eliminates sequence errors, amino acid substitutions, and structural modifications
- Endotoxin (LAL)
- Lipopolysaccharide contamination from bacterial sources
- <1.0 EU/mg
- <0.1 EU/mg
- >1.0 EU/mg, no method listed, 'ND' without detection limit
- LAL Kinetic Chromogenic with <0.1 EU/mg confirms peptide won't trigger immune activation or cytokine release in assays
- Sterility Testing
- Absence of viable microbial contamination
- No Growth (14-day incubation)
- Growth Detected, contamination observed, incomplete incubation period
- Direct inoculation with No Growth at 14 days confirms absence of bacteria, yeast, and mould. Mandatory for cell culture applications
- Peptide Content
- Actual peptide weight as percentage of total lyophilised mass
- ≥80%
- ≥85%
- <75%, no correction factor provided, TFA salt content not disclosed
- Content percentage corrects for residual TFA, acetate, and water. Critical for accurate dosing when calculating molarity